CCS
MDXG icon

Crosspoint Capital Strategies’s MiMedx Group MDXG Stock Holding History

Crosspoint Capital Strategies’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-246,269
Closed -$3.69M – 146
2017
Q2 		$3.69M Buy
+246,269
New +$3.29M 3.22% 5

Other funds holding MDXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Crosspoint Capital Strategies's MDXG Position: Q3 2017 in Review

Crosspoint Capital Strategies sold out of MiMedx Group (MDXG) in Q3 2017, closing a stake of 246,269 shares — an estimated $3.69M sold.

Crosspoint Capital Strategies first reported a position in MDXG in Q2 2017 and held it in 1 quarter. The position peaked at $3.69M in Q2 2017. 232 funds tracked by Wall St. Rank hold MDXG as of Q3 2017.

  • Crosspoint Capital Strategies reported no remaining MiMedx Group position as of Q3 2017 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 246,269 MiMedx Group shares in Q3 2017, an estimated $3.69M.
  • Crosspoint Capital Strategies first reported a position in MiMedx Group in Q2 2017 and held it in 1 quarter.
  • Crosspoint Capital Strategies's MiMedx Group position peaked at $3.69M in Q2 2017.
  • 232 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2017.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2017, filed 6 Nov 2017.